Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline vs Ceftriaxone in Community-Acquired Pneumonia (FOCUS 1)
NCT00621504Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 23
01
Overview
A Phase 3 trial of ceftaroline fosamil in community acquired pneumonia (CAP), sponsored by Forest Laboratories. Started Jan 2008; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00621504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621504.